NASDAQ · GANX
Gain Therapeutics, Inc.
Healthcare · Biotechnology
$1.15
Down-$0.04 (-3.48%)
Updated Nov 4, 2026, 10:40 PM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 148.53M
- P/E ratio
- -6.72
- Dividend yield
- 0.00%
- 52-week range
- $1.11 – $3.07
- Volume
- 193.74K
- Avg. volume
- 1.01M
Price performance · GANX
GANX price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
GANX closed at $1.15 after 21 trading sessions, down 31.14% for the selected period.
- Last close
- $1.15
- Period change
- -31.14%
- Period low
- $1.13
- Period high
- $1.67
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $1.13 | $1.19 | $1.13 | $1.15 | 193.74K |
| Nov 2, 2026 | $1.15 | $1.20 | $1.12 | $1.13 | 268.67K |
| Oct 30, 2026 | $1.18 | $1.195 | $1.11 | $1.13 | 364.65K |
| Oct 29, 2026 | $1.20 | $1.25 | $1.17 | $1.19 | 177.2K |
| Oct 28, 2026 | $1.16 | $1.20 | $1.16 | $1.195 | 400.43K |
| Oct 27, 2026 | $1.16 | $1.21 | $1.14 | $1.17 | 508.34K |
| Oct 26, 2026 | $1.28 | $1.28 | $1.14 | $1.15 | 811.02K |
| Oct 23, 2026 | $1.33 | $1.3432 | $1.22 | $1.26 | 645.03K |
| Oct 22, 2026 | $1.18 | $1.33 | $1.16 | $1.29 | 2.75M |
| Oct 21, 2026 | $1.20 | $1.23 | $1.15 | $1.19 | 609.77K |
| Oct 20, 2026 | $1.23 | $1.295 | $1.17 | $1.19 | 517K |
| Oct 19, 2026 | $1.26 | $1.2899 | $1.21 | $1.25 | 532.17K |
| Oct 16, 2026 | $1.32 | $1.377 | $1.235 | $1.26 | 467.38K |
| Oct 15, 2026 | $1.32 | $1.41 | $1.31 | $1.33 | 510.82K |
| Oct 14, 2026 | $1.37 | $1.42 | $1.295 | $1.32 | 851.3K |
| Oct 13, 2026 | $1.58 | $1.58 | $1.40 | $1.41 | 800.29K |
| Oct 12, 2026 | $1.65 | $1.65 | $1.565 | $1.57 | 319.8K |
| Oct 9, 2026 | $1.61 | $1.66 | $1.6099 | $1.64 | 328.69K |
| Oct 8, 2026 | $1.66 | $1.675 | $1.61 | $1.615 | 361.86K |
| Oct 7, 2026 | $1.66 | $1.69 | $1.64 | $1.67 | 373.93K |
| Oct 6, 2026 | $1.70 | $1.75 | $1.655 | $1.67 | 646.56K |
Latest GANX news
The latest Smart Investors Daily articles mentioning GANX.
Stock researchMarket Activity · Options
Company
Market Activity
Research & News

